Kashiwabara Misako, Asano Kazuhito, Mizuyoshi Tomomi, Kobayashi Hitome
Graduate School of Nursing and Rehabilitation Sciences, Showa University Graduate School, Midori-ku, Yokohama, 226-8555, Japan.
Division of Physiology, School of Nursing and Rehabilitation Sciences, Showa University, 1865 Touka-Ichiba, Midori-Ku, Yokohama, 226-8555, Japan.
BMC Complement Altern Med. 2016 May 20;16:132. doi: 10.1186/s12906-016-1123-z.
Quercetin, a dietary flavonoid found in many fruits, red wine and onion, among others, has been reported to have potent anti-oxidant, anti-viral and anti-cancer effects. Although quercetin is also reported to have anti-inflammatory and anti-allergic effects, the precise mechanisms by which quercetin favorably modify the clinical conditions of allergic diseases such as allergic rhinitis (AR). The present study was designed to examine the influence of quercetin on the development of AR by using AR model rats.
Sprague-Dawley (SD) rats were sensitized with toluene 2,4-diisocyanate (TDI) by intranasal instillation of a 10 % TDI in ethyl acetate in a volume of 5 μl once a day for 5 consecutive days. This sensitization procedure was repeated after a 2-day interval. After 5 days of the second sensitization, rats were treated with various doses of quercetin once a day for 2 to 7 days. Nasal allergy-like symptoms, which were induced by bilateral application of 5 μl of 10 % TDI in ethyl acetate, were assessed by counting sneezing and nasal rubbing behaviors for 10 min just after TDI nasal challenge. The levels of substance P (SP), calcitonin gene-related peptide (CGRP) and nerve growth factor (NGF) in nasal lavage fluids obtained 6 h after TDI nasal challenge was examined by ELISA.
Oral administration of quercetin for 5 and 7 days, but not 2 and 3 days, could inhibit sneezing and nasal rubbing movements, which were increased by TDI nasal challenge. The minimum dose that caused significant inhibition was 25 mg/kg. Oral administration of quercetin at more than 25 mg/kg for 5 days significantly inhibited the increase in SP, CGRP and NGF contents in nasal lavage fluids induced by TDI nasal challenge.
The present results strongly suggested that quercetin will be a good candidate for the supplement on the management and treatment of allergic diseases, especially AR.
槲皮素是一种存在于许多水果、红酒和洋葱等食物中的膳食类黄酮,据报道具有强大的抗氧化、抗病毒和抗癌作用。尽管也有报道称槲皮素具有抗炎和抗过敏作用,但槲皮素改善过敏性疾病(如过敏性鼻炎,AR)临床症状的确切机制尚不清楚。本研究旨在通过使用AR模型大鼠来研究槲皮素对AR发生发展的影响。
将10%的甲苯二异氰酸酯(TDI)溶于乙酸乙酯,以5 μl的体积经鼻内滴注,每天1次,连续5天,使Sprague-Dawley(SD)大鼠对TDI致敏。间隔2天后重复该致敏程序。在第二次致敏5天后,大鼠每天接受不同剂量的槲皮素治疗,持续2至7天。通过双侧应用5 μl 10%的TDI溶于乙酸乙酯诱发鼻过敏样症状,在TDI鼻激发后立即计数10分钟内的打喷嚏和擦鼻行为来评估。通过ELISA检测TDI鼻激发6小时后获得的鼻灌洗液中P物质(SP)、降钙素基因相关肽(CGRP)和神经生长因子(NGF)的水平。
口服槲皮素5天和7天,但不是2天和3天,可抑制TDI鼻激发所增加的打喷嚏和擦鼻动作。产生显著抑制作用的最小剂量为25 mg/kg。口服25 mg/kg以上的槲皮素5天可显著抑制TDI鼻激发诱导的鼻灌洗液中SP、CGRP和NGF含量的增加。
目前的结果强烈表明,槲皮素有望成为管理和治疗过敏性疾病,尤其是AR的良好补充剂。